Companies: 10,795·Total market cap: $144.5T
CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active
$0.37
+$0.00(+0.46%)
Market Cap$4542787
P/E Ratio
52W High$3.232
52W Low$0.271

CollPlant Biotechnologies Ltd. (CLGN) Revenue

Annual & quarterly revenue history · segment & region breakdown

CLGN · revenue · updated Jun 9, 2026

Core revenue metrics

CollPlant Biotechnologies Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
11.68×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$7K
57 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · CollPlant Biotechnologies Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
CLGN revenue by year · CLGN revenue history · CLGN annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CollPlant Biotechnologies Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CollPlant Biotechnologies Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CollPlant Biotechnologies Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CLGN revenue · 4 questions

CLGN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CLGN revenueCLGN annual revenuewhat is CLGN revenueCLGN TTM revenue

Source: FMP · CollPlant Biotechnologies Ltd. SEC filings · GAAP · CollPlant Biotechnologies Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026